Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial Intelligence Driven Adjusted OCT-Based Classification System for Diabetic Macular Edema (AIDME).

Rodrigo Abreu-González1,2, Gonzalo Quezada-Peralta3, Patricia Udaondo4,5

  • 1Ophthalmology Department, University Hospital of La Candelaria, Tenerife, Spain.

Clinical Ophthalmology (Auckland, N.Z.)
|May 27, 2026
PubMed
Summary

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aganirsen as a Therapeutic Alternative for Modulating Corneal Neovascularization: A Real-World Case Series Study.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Validation of artificial intelligence algorithm LuxIA for screening of diabetic retinopathy from a single 45° retinal colour fundus images: the CARDS study.

BMJ open ophthalmology·2025
Same author

Trachoma and the Importance of Sexual Infective Route in Developed Countries. Comment on Gallenga et al. Why the SAFE-<i></i> Strategy for Trachoma? Are <i>Musca sorbens</i> or <i>Scatophaga stercoraria</i> Really the Culprit?-A Brief Historical Review from an Italian Point of View. <i>Pathogens</i> 2023, <i>12</i>, 1419.

Pathogens (Basel, Switzerland)·2024
Same author

Recovery course of persistent posterior subretinal fluid after successful repair of rhegmatogenous retinal detachment.

European journal of ophthalmology·2023
Same author

Comment on Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser. <i>J. Clin. Med.</i> 2023, <i>12</i>, 1127.

Journal of clinical medicine·2023
Same author

Systemic lupus erythematosus purtscher like retinopathy: Optical coherence tomography angiography assessment implications.

European journal of ophthalmology·2023
This summary is machine-generated.

A new scoring system for Diabetic Macular Edema (DME) effectively classifies disease severity using OCT imaging. This classification correlates well with visual acuity, aiding clinical decisions for DME patients.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Diabetic Macular Edema (DME) poses a significant threat to vision in diabetic patients.
  • Accurate classification of DME severity is crucial for effective treatment and prognosis.
  • Current classification methods may not fully capture the complexity of DME pathology.

Purpose of the Study:

  • To develop and validate an adjusted scoring system for Diabetic Macular Edema (DME).
  • To integrate quantitative (retinal thickness, fluid) and qualitative (structural disorganization) parameters for DME classification.
  • To correlate the new classification system with visual acuity outcomes.

Main Methods:

  • Analysis of optical coherence tomography (OCT) data from 71 DME patients.
Keywords:
artificial intelligencediabetic macular edemadiagnostic/tests investigationimagingoptical coherence tomographyvision

Related Experiment Videos

  • Quantitative parameters (retinal thickness, intraretinal fluid, subretinal fluid) scored 0-2 points.
  • Qualitative biomarkers (DRIL, ERM) incorporated as severity modifiers.
  • Classification into Mild (0-3), Moderate (4-6), and Severe (>7) groups based on total score.
  • Validation using visual acuity (logMAR) and ROC curve analysis (AUC=0.89).

    • Main Results:

    • The scoring system successfully classified patients into mild, moderate, and severe DME groups.
    • Significant differences in visual acuity (logMAR) were observed between the groups (p=0.014).
    • The system demonstrated a strong correlation between DME severity and visual impairment.

    Conclusions:

    • The adjusted scoring system provides a robust method for correlating DME severity with visual acuity.
    • Integrating quantitative and qualitative OCT biomarkers offers a practical approach for DME stratification.
    • This classification system has the potential to improve clinical decision-making and guide research in DME management.